glp 1 receptor agonists canada GLP-1 Agonist Market Size, Share, Growth, 2034 Frontiers | GLP-1 Receptor Agonists:

Governments looking to reduce the costs of healthcare and boost economic productivity also need to tread carefully when encouraging the use of GLP-1 drugs in people with obesity without addressing the wider socio-economic challenges patients face as well as the problems posed by the rise in ultra-processed food and poor provision of physical exercise facilities

doi: 10.1074/jbc.M206006200

His A1c has decreased to 5.6%

References Abdelaal M, le Roux CW, Docherty NG

Table 10 provides a comparative overview of common bariatric surgeries

Weight loss can vary widely among individuals, but many people lose between 5% to 10% of their body weight over six months to a year